CABG is the best therapy for coronary artery disease
D Taggart (Oxford, UK), based on a detailed review of the evidence, argues that CABG remains the best therapy for coronary artery disease in 2015.
Complete revascularisation - evidence in CABG
P Kolh (Leige, Belgium) assesses the evidence for the importance of completeness of myocardial revascularisation in coronary bypass surgery.
Complete revascularisation - evidence in PCI
C Hamm (Bad Nauheim, Germany) reviews the evidence for the benefits of complete revascularisation in percutaneous coronary intervention.
ESC-EACTS 2010 revascularisation guidelines viewpoint & debate
D Taggart (Oxford, UK) gives his perspective on the 2010 European revascularisation guidelines, based on evidence from the literature. A discussion follows.
ESC-EACTS 2010 revascularisation guidelines implementation
P Kolh (Liege, Belgium) describes the development of the 2010 European revascularisation guidelines. He emphasises the importance of the heart team and evidence-based protocols. He explores the indications for the different treatment options in stable disease, updating the guidelines with five year SYNTAX data.
SYNTAX 4 year results
D Taggart (Oxford, UK) presents pre-syntax evidence for CABG vs PCI, before analyzing the results of the SYNTAX trial at four years.
SYNTAX trial 5 year results
D Taggart (Oxford, UK) presents the 5 year results of the SYNTAX trial, in the context of other evidence in coronary revascularisation.
Effect of SYNTAX trial in Europe
P Kolh (Liege, Belgium) considers whether the SYNTAX trial has changed coronary artery disease practice in Europe. He reviews the results, examines the guidelines and emphasises the importance of risk models.
SYNTAX trial influence in the USA
JF Sabik (Cleveland, USA) considers whether the SYNTAX trial has changed practice in the USA and, if not, why not? He reviews the trial design and results before looking at registry data to inform about current patterns of coronary artery disease management. He looks at more recent trials which also...
UK revascularisation heart team
M Bhabra (Wolverhampton, UK) describes the local structure of his heart team.
Revascularisation heart team - USA view
E Verrier (Washington, USA) discusses the revascularisation heart team from a USA perspective.
Revascularisation heart team information requirements
P Kolh (Leige, Belgium) promotes the value of the heart team and questions whom should be involved. He considers patient information, medical ethics, time, risk stratification
Revascularisation heart team - surgeon's view
D Taggart (Oxford, UK) emphasises the need for a heart team to ensure that patients receive the most appropriate guideline-driven interventions.
Revascularisation heart team - cardiologist's view
M Norell (Wolverhampton, UK) talks about the role of the revascularisation multidisclipinary heart team from a cardiology viewpoint.
Revascularisation heart team decision
H Luckraz (Wolverhampton, UK) assesses whether decisions made by the heart team are enacted.
Proximal LAD disease case based discussion
M Dweck (Edinburgh, UK) presents a case of isoated proximal LAD disease. G Laufer (Vienna, Austria) argues in favour of surgery, while C Hamm (Bad Nauheim, Germany) puts forward the case for PCI. P Kohl (Liege, Belgium) considers how the European guidelines should help in this case.
NSTEMI case based discussion
Prof G Laufer (Vienna, Austria) argues in favour of CABG in multivessel disease. P Kolh (Liege, Belgium) considers the case in the context of European guidelines. A discussion follows.
UK database revascularisation data
B Bridgewater ( Manchester , UK ) explains the analysis of the UK database data and demonstrates visualisation of the data via the Blue Book Online. A comparison of single versus bilateral mammary usage in coronary revascularisation is then made.
Recent advances in interventional cardiology
N Curzen (Southampton, UK) explains the importance of physiological ischaemia and FFR in deciding optimal management for coronary disease.
MIDCAB programme setup
E Akowuah (Middlesbrough, UK) shares his experience of setting up a minimally-invasive coronary surgery programme.
MIDCAB procedure evolution
R Stanbridge (London, UK) describes the evolution of minimally invasive coronary surgery from his initial experience in 1995, and considers the results of the procedure.
Thoracoscopic IMA harvest
A de Souza (London, UK) describes his technique for endoscopic internal mammary artery harvest.
Off pump CABG is here to stay
M Lemma (Milan, Italy) puts forward the argument in favour of off-pump coronary bypass surgery.
Off pump CABG - in favour
M S Uva (Lisbon, Portugal) argues in favour of off-pump coronary bypass surgery, reviewing the evidence from randomised controlled trials and meta-analyses.
Off pump CABG should be abandoned
J Sabik (Cleveland, USA), as part of a debate, argues that off-pump CABG should be abandoned as our default procedure. He reviews metaanalyses and results from the major trials to support his view.
Off pump CABG - against
J Pepper (London, UK) presents evidence against the use of off-pump coronary bypass surgery.
Off pump CABG discussion
D Taggart (Oxford, UK) leads an audience discussion on the merits of off-pump coronary bypass surgery.
Off-pump CABG database evidence 2012
B Bridgewater (Manchester, UK) presents provisional analysis of off-pump vs on-pump CABG from the SCTS database.
Off-pump CABG data to inform practicing sureons
D Taggart (Oxford, UK) undertakes a detailed exploration of the evidence for and against off-pump CABG.
Off-pump CABG - surgeon's view
G Angelini (Bristol, UK) talks about surgical attitudes to evidence-based medicine, professional competition and lack of innovation.
Surgical practice polarisation
A Wechsler (Philadelphia, USA) explores some of the reasons for polarisation of surgical opinion, including intuition and the retntion of biases.
Off-pump CABG anaesthetic viewpoint
C Palin (Oxford, UK), a cardiac anaesthetist, explains his view on how practice has become so polarised. This is followed by a panel and audience debate.
Cardiology view of off pump CABG
C Hamm (Bad Nauheim, Germany) gives a brief assessment of off pump surgery from a cardiologist's viewpoint.
Off-pump CABG future
D Glineur (Brussels, Belgium) discusses the off-pump CABG trials and argues for the use of bilateral internal mammary arteries as a composite Y-graft.
Ultrasound to reduce CVA in off pump CABG
C Royse (Melbourne, Australia) explains why he believes that the key to reducing risk of stroke is aortic assessment.
One arterial graft is sufficient
G. Angelini (London, UK) considers the evidence for single versus multiple arterial grafts in coronary bypass surgery, looking to explain why saphenous vein remains the second conduit of choice in the majority of cases worldwide.
Is bilateral IMA use the gold standard?
J Sabik (Cleveland, USA) considers the evidence for bilateral internal mammary artery usage in coronary bypass surgery. He uses data from the large Cleveland clinic registry to explore the importance of time, coronary vessel anastomosed, conduit used and patient factors in determining outcomes.
Radial artery as the second conduit
D Taggart (Oxford, UK) reviews the evidence for using the radial artery as the first choice of second conduit in coronary bypass surgery.
Conduit alternatives
R Hasan (Manchester, UK) gives an overview of the alternative conduits for bypass grafting. A de Souza (London, UK) reviews to evidence for these conduits.
Bilateral IMA evidence
D Taggart (Oxford, UK) reviews the evidence for bilateral internal mammary artery use in coronary bypass surgery.
BIMA evidence
D Taggart (Oxford, UK) argues in favour of using bilateral internal mammary arteries for surgical revascularisation.
SCTS database evidence for BIMA
B Bridgewater (Manchester, UK) presents figures from the SCTS database comparing single versus bilateral mammary artery use in CABG.
RIMA to LAD revascularisation
N Howell (Birmingham, UK) explores whether RIMA-LAD revascularisation is equivalent to LIMA-LAD
Adequacy of IMA composite grafts
M Ruel (Ottawa, Canada) discusses whether single internal mammary artery grafts can adequately supply the heart.
Optimising vein graft outcomes
J Pepper (London, UK) considers the causes of vein graft occlusion before looking at possible ways to improve results.
In favour of open vein harvest
D Souza (Örebro, Sweden) argues that an open vein harvest technique including peri-adventitial fat is best to optimise long-term patency.
Endoscopic vein harvest is best
J Zacharias (Blackpool, UK) shows a video demonstration of the technique before reviewing the evidence for and against endoscopic vein harvest.
Surgical interventions for veins
G. Angelini (London, UK) describes surgical techniques to improve vein graft patency rates.
Vein graft stents
D Taggart (Oxford, UK) describes the VEST trial of external venous support for coronary bypass grafts.
Vein graft external stenting
D Taggart (Oxford, UK) looks at the evidence for external stenting of vein grafts to optimise long-term outcomes.